key: cord-0075342-hy2kp413
authors: Gobel, Barbara Holmes
title: Symptom Management: Introduction
date: 2022-03-03
journal: Semin Oncol Nurs
DOI: 10.1016/j.soncn.2022.151250
sha: 2e2567c0fbb1ae73b08161784be551f25e953497
doc_id: 75342
cord_uid: hy2kp413

nan

When I started working on this issue of Seminars in Oncology Nursing, I could not have imagined that we would be facing the third year of an international pandemic due to coronavirus disease 2019 . During these past 2 years, we have seen dramatic changes in the world, our own countries, and our personal and professional lives. Also during this time, we have wrestled with how to provide optimal care to patients with cancer and their significant others. How do you provide optimal care to patients facing a diagnosis of cancer, undergoing a variety of cancer treatments, and at times facing death due to cancer when patients and caregivers are in facemasks and loved ones are not able to accompany the patient to appointments, treatment, and hospitalization? As Paterson, et al 1 stated in an article in published in Seminars in Oncology Nursing during the early stages of the pandemic, "This pandemic poses several challenges for oncology services. Oncology nurses are providing a pivotal role in the care and management of the novel COVID-19 in the year landmarked as the "International Year of the Nurse."

The vital role of oncology nurses providing evidence-based symptom management for patients undergoing cancer care and beyond is undeniable. Symptoms that patients experience due to cancer and cancer treatment are nurse sensitive because nurses have a direct impact on the prevention, assessment, and management of these symptoms. In this issue of Seminars in Oncology Nursing, key cancerrelated symptoms are reviewed along with current available evidence to support optimal patient care. In this issue, authors stress the importance of the need for collaborative interprofessional care by a team of dedicated cancer care professionals.

The first article in this issue, written by Brant, a leading expert in cancer-related pain, reviews both acute cancer-related pain and chronic pain syndromes. She identifies key elements of the assessment of pain, which can provide insight into the suffering experienced by the patient in pain. A multimodal approach to cancerrelated pain management is emphasized using pharmacologic, nonpharmacologic, and complementary therapies.

Oakvik and Ready, patient care experts, provide a review of the cancer-related management of cancer anorexia-cachexia syndrome (CACS). The authors stress the critical role of nutrition in patients with cancer, particularly patients undergoing cancer treatment. The authors present guidelines for the prevention of cancer anorexiacachexia syndrome and the assessment of this potentially debilitating syndrome. Evidence-based management strategies are reviewed including nutritional, pharmacologic, nonpharmacologic, and complementary therapies.

Henry, an expert mental health practitioner, describes the symptom management of depression and anxiety in cancer and stresses the importance of emotional support of patients by nurses. She provides guidelines for providing this support and tools that nurses can use to assess and measure anxiety and depression. Post-traumatic stress disorder (PTSD) and treatment-resistant depression in patients with cancer are also reviewed. Case vignettes illustrate the assessment and management of these symptoms by nurses.

Palliative care experts, Obarzanek and Campbell, review the distressing symptom of dyspnea in patients with advanced disease. These authors stress the importance of timely and accurate assessment of dyspnea, which can lead to prompt intervention. They present what they describe as a hierarchal approach to the nonpharmacologic and pharmacologic approach to this symptom.

The fifth article in this issue, written by Isozaki and Brant, is a review of the cancer-related symptom of mucositis. The authors, both clinical care experts, describe a symptom that can lead to multiple complications and substantial health-care-related costs. The authors stress the importance of the prevention of mucositis using both nonpharmacologic and pharmacologic strategies. They discuss evidence-based assessment and treatment strategies, including new and innovative ones, and the critical need for nursing care.

Cope, a leading expert in clinical practice, reviews current thinking on chemotherapy-induced nausea and vomiting (CINV). She provides updated antiemetic guidelines from international cancer organizations and its impact on CINV in the prevention and delayed phase of therapy. Her evidence-based review of treatment options underscores the key role that nurses play in the management of CINV for patients undergoing oncologic therapy, including assessment, education on CINV and its prevention, and ongoing assessment and management during chemotherapy treatments.

In the final article in this issue, Professors Matthews and Wang review the evidence on sleep wake disturbance (SWD) in adults with cancer. They provide an up-to-date review of the prevalence, impact, causes, and risk factors of this debilitating problem for millions of people with cancer. Strategies for the management of SWD in the context of cancer care delivery are discussed in the context of the predictive preventive and personalized medicine framework (PPPM). The authors

Oncology nursing during a pandemic: critical reflections in the context of COVID-19

Seminars in Oncology Nursing journal homepage: https://www.journals.elsevier.com/seminars-in-oncology-nursing discuss the impact of COVID-19 on SWDs as well as implications for future research in this area of symptom management.The information in this issue of Seminars in Oncology Nursing will help to inform oncology nurses of the current available evidence regarding the prevalence, impact, causes, and risk factors of a variety of cancer and cancer-treatment related symptoms. The authors of these articles hope to help educate oncology nurses on the need for timely and accurate assessment of these symptoms, which can lead to prompt treatment using a multimodal approach to care. I want to thank the each of the authors who have contributed to this issue. We are working in the midst of unprecedented world events, and yet, these authors have been compelled to share their time, talent, and expertise to add to the body of knowledge that helps to support optimal cancer patient care.